Loxo CEO on genetically targeted cancer drugs

In this video

Share

Loxo CEO on genetically targeted cancer drugs

CNBC's Meg Tirrell discusses new cancer-fighting technology with Loxo CEO Dr. Josh Bilenker.
04:17
Mon, Jun 4 201812:45 PM EDT